Rhythm Pharmaceuticals, Inc.
Key Metrics
Market Snapshot
About
Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare genetic disorders of obesity. The company markets setmelanotide, an FDA-approved melanocortin-4 receptor agonist for treating rare diseases caused by impaired MC4R pathway signaling. Rhythm is advancing a pipeline of peptide therapeutics targeting genetic obesity and related metabolic disorders.